'엑스탄디', 비전이성 호르몬 민감성 전립선암 치료제로 EU 승인 - 헬스조선

( ) (EU) . (mHSPC) (CRPC) 3 .EU 23() , ?BCR) (nmHSPC) ?. ? (ADT) . ? ? , (nmCRPC) .
? ( ? 3 ? ?57.6% . ? ? ?36.9% . ? ? ? ? ? .
? , ?? 20~40% 10 ?. ? 90% ? .

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute